Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Agilon Health (AGL) Equity Income (2022 - 2025)

Agilon Health's Equity Income history spans 4 years, with the latest figure at -$33.1 million for Q4 2025.

  • For Q4 2025, Equity Income fell 1126.87% year-over-year to -$33.1 million; the TTM value through Dec 2025 reached -$1.8 million, down 112.24%, while the annual FY2025 figure was -$1.8 million, 112.24% down from the prior year.
  • Equity Income reached -$33.1 million in Q4 2025 per AGL's latest filing, down from $13.1 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $14.7 million in Q3 2023 to a low of -$33.1 million in Q4 2025.
  • Average Equity Income over 4 years is $2.3 million, with a median of $5.5 million recorded in 2024.
  • The largest YoY upside for Equity Income was 541.57% in 2025 against a maximum downside of 1126.87% in 2025.
  • A 4-year view of Equity Income shows it stood at $7.2 million in 2022, then tumbled by 210.64% to -$8.0 million in 2023, then skyrocketed by 66.4% to -$2.7 million in 2024, then plummeted by 1126.87% to -$33.1 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Equity Income are -$33.1 million (Q4 2025), $13.1 million (Q3 2025), and $5.4 million (Q2 2025).